Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07274163

Ambispective Registry of Patients Affected by Lung Cancer

Lung cancer is one of the most common cancers and the leading cause of cancer-related death. It is often diagnosed late, and there are different types of lung cancer. Today, many patients benefit from targeted therapies and immunotherapy, which have improved survival.

This study will create an ambispective clinical registry of all lung cancer patients treated at Policlinico San Matteo.

The registry will collect data from 2019 to 2035 to better understand: 10-year overall survival, how the disease progresses over time, how patients respond to treatments and possible side effects, how patient and tumor characteristics influence treatment choices, how different therapies work in real-world practice.

All data will be securely collected whithin REDCap platform and used to improve future care and research.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione IRCCS Policlinico San Matteo

Pavia, 27100, Italy

Location status: Recruiting

Location contact

Francesco Agustoni

CONTACT

[email protected]

0382501433

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients ≥ 18 years diagnosed with and/or treated for lung cancer at the department of SC Oncologia 1 Unit of the Fondazione IRCCS Policlinico San Matteo;
  • Prospective patients (or their or legal guardians) who have the ability to understand and be willing to sign a written informed consent document;
  • Retrospective patients who have signed the institutional document allowing the use of their data for research on their disease.

Exclusion criteria

  • Patients who are unable to understand informed consent document.

Treatment and study plan

Primary outcomes

  1. 10 years overall survival

    Time frame: 10 years

Study contacts

Contact information is provided by the study sponsor or research team.

Francesco Agustoni

CONTACT

[email protected]

0382501433

Sponsors and collaborators

Lead sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Other

Registry information

Important dates

Study start
2019
Primary completion
2035
Study completion
2035
First posted
Dec 10, 2025
Registry last updated
Dec 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.